Schonfeld Strategic Advisors LLC Biora Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	$1.35 - $4.89 $17,415 - $63,080	-12,900 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$0.67 - $3.41 $8,643 - $43,989	12,900 New	12,900 $20,000
Q1 2021 May 17, 2021	SELL	$3.91 - $7.31 $110,262 - $206,142	-28,200 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.27 - $9.48 $363,208 - $1.05 Million	-111,073 Reduced 79.75%	28,200 $150,000
Q3 2020 Nov 16, 2020	SELL	$7.71 - $10.79 $372,315 - $521,049	-48,290 Reduced 25.75%	139,273 $1,000
Q2 2020 Aug 14, 2020	BUY	$9.0 - $13.12 $1.69 Million - $2.46 Million	187,563 New	187,563 $1.69 Million

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $299M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.